Dyadic International (DYAI) Assets Growth (3y) (2020 - 2026)
Powered by 
Analysis
Dyadic International (DYAI) Assets Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.85 Bn | 192.86 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.09 Bn | 176.91 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.06 Bn | 123.21 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.82 Bn | 73.82 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.39 Bn | 55.21 Bn | 1.37 Bn |
| 6 | Moderna | 54.31 Bn | 49.17 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.13 Bn | 29.82 Bn | 992.69 Mn |
| 8 | Biogen | 31.90 Bn | 30.62 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.23 Bn | 29.23 Bn | 1.16 Mn |
| 10 | Dyadic International | 17.59 Mn | 9.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -15.21% |
| Dec 31, 2025 | -10.15% |
| Sep 30, 2025 | -8.46% |
| Jun 30, 2025 | -22.11% |
| Mar 31, 2025 | -92.48% |
| Dec 31, 2024 | -22.46% |
| Sep 30, 2024 | -23.21% |
| Jun 30, 2024 | -26.20% |
| Mar 31, 2024 | -23.46% |
| Dec 31, 2023 | -35.10% |
| Sep 30, 2023 | -33.69% |
| Jun 30, 2023 | -31.01% |
| Mar 31, 2023 | -28.73% |
| Dec 31, 2022 | -28.46% |
| Sep 30, 2022 | -26.62% |
| Jun 30, 2022 | -24.53% |
| Mar 31, 2022 | 662.13% |
| Dec 31, 2021 | -21.06% |
| Dec 31, 2020 | -16.00% |